Daxor Corporation (DXR)

USD 7.95

(-1.21%)

Market Cap (In USD)

38.45 Million

Revenue (In USD)

1.28 Million

Net Income (In USD)

280.64 Thousand

Avg. Volume

6747.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
7.19-10.04
PE
-88.33
EPS
-0.09
Beta Value
-0.541
ISIN
US2394671034
CUSIP
239467103
CIK
27367
Shares
4836930.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. Michael Richard Feldschuh
Employee Count
-
Website
https://www.daxor.com
Ipo Date
1983-07-25
Details
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

More Stocks